AstraZeneca LP v. Prinston Pharmaceutical Inc.

Application Number	Patent Number	External Links
-	US6251910	Espacenet Google Patents
-	US6525060	Espacenet Google Patents
-	US7250419	Espacenet Google Patents
-	US7265124	Espacenet Google Patents
-	US8425934	Espacenet Google Patents

COMPLAINT FOR PATENT INFRINGEMENT filed against Prinston Pharmaceutical Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1827936.) - filed by AstraZeneca LP, AstraZeneca UK Limited, AstraZeneca Pharmaceuticals LP, AstraZeneca AB. (Attachments: # 1 Exhibit A, # 2 Exhibit B-E, # 3 Civil Cover Sheet)(sec) (Entered: 11/16/2015)

2015-11-16

1

Download

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (sec) (Entered: 11/16/2015)

2015-11-16

1

View

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 10/03/2015. Date of Expiration of Patent: SEE ANDA.Thirty Month Stay Deadline: 1/20/2019. (sec) (Entered: 11/16/2015)

2015-11-16

1

Download

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,251,910; 6,525,060; 7,250,419; 7,265,124; 8,425,934. (sec) (Entered: 11/16/2015)

2015-11-16

1

View

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for AstraZeneca LP filed by AstraZeneca LP. (sec) (Entered: 11/16/2015)

2015-11-16

1

View

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for AstraZeneca AB filed by AstraZeneca AB. (sec) (Entered: 11/16/2015)

2015-11-16

1

View

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for AstraZeneca UK Limited filed by AstraZeneca UK Limited. (sec) (Entered: 11/16/2015)

2015-11-16

1

View

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for AstraZeneca Pharmaceuticals LP filed by AstraZeneca Pharmaceuticals LP. (sec) (Entered: 11/16/2015)

2015-11-16

1

View

Summons Issued

2015-11-16

1

No Actions

Case Assigned/Reassigned

2015-11-18

1

No Actions

SUMMONS Returned Executed by AstraZeneca LP, AstraZeneca UK Limited, AstraZeneca Pharmaceuticals LP, AstraZeneca AB. Prinston Pharmaceutical Inc. served on 11/17/2015, answer due 12/8/2015. (Smyth, Benjamin) (Entered: 11/25/2015)

2015-11-25

1

View

STIPULATION TO EXTEND TIME Answer to Complaint to through and including January 8, 2016 - filed by Prinston Pharmaceutical Inc.. (Farnan, Kelly) (Entered: 12/04/2015)

2015-12-04

1

View

~Util - Set/Reset Answer Deadline AND SO ORDERED

2015-12-04

1

No Actions

MOTION for Pro Hac Vice Appearance of Attorney Mark J. Feldstein, Charles E. Lipsey, Ryan P. O'Quinn and Jill K. MacAlpine - filed by AstraZeneca AB, AstraZeneca LP, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited. (Attachments: # 1 Certification for Mark J. Feldstein, Charles E. Lipsey, Ryan P. O'Quinn and Jill K. MacAlpine)(Silver, Daniel) (Entered: 12/07/2015)

2015-12-07

1

View

SO ORDERED

2015-12-08

1

No Actions

Add Attorneys - PHV only

2015-12-14

1

No Actions

ANSWER to 1 Complaint, with Jury Demand, COUNTERCLAIM against AstraZeneca AB, AstraZeneca LP, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited by Prinston Pharmaceutical Inc..(Farnan, Kelly) (Entered: 01/08/2016)

2016-01-08

1

View

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Zhejiang Huahai Pharmaceutical Co., Ltd. for Prinston Pharmaceutical Inc. filed by Prinston Pharmaceutical Inc.. (Farnan, Kelly) (Entered: 01/08/2016)

2016-01-08

1

View

MOTION for Pro Hac Vice Appearance of Attorney Steven E. Feldman, Daniel R. Cherry and Sherry L. Rollo of Hahn Loeser & Parks LLP - filed by Prinston Pharmaceutical Inc.. (Farnan, Kelly) (Entered: 01/13/2016)

2016-01-13

1

View

SO ORDERED

2016-01-13

1

No Actions

Order Setting Rule 16(b) Conference: A Scheduling Conference is set for 2/10/2016, at 2:30 PM in Courtroom 6A before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 1/14/2016. (nms) (Entered: 01/19/2016)

2016-01-19

1

View

NOTICE of Appearance by Christine Dealy Haynes on behalf of Prinston Pharmaceutical Inc. (Haynes, Christine) (Entered: 01/26/2016)

2016-01-26

1

View

Add Attorneys - PHV only

2016-01-28

1

No Actions

ANSWER to 12 Answer to Complaint, Counterclaim by AstraZeneca AB, AstraZeneca LP, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited.(Silver, Daniel) (Entered: 02/01/2016)

2016-02-01

1

View

Proposed Scheduling Order, by AstraZeneca AB, AstraZeneca LP, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited. (Silver, Daniel) Modified on 2/9/2016 (nms). (Entered: 02/08/2016)

2016-02-08

1

View

Scheduling Conference

2016-02-10

1

No Actions

Official Transcript of Scheduling Conference held on 02-10-16 before Judge Richard G. Andrews. Court Reporter/Transcriber Leonard A. Dibbs. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 3/3/2016. Redacted Transcript Deadline set for 3/14/2016. Release of Transcript Restriction set for 5/11/2016. (lad) (Entered: 02/11/2016)

2016-02-11

1

View

PROPOSED Scheduling Order, by AstraZeneca AB, AstraZeneca LP, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited. (Silver, Daniel) Modified on 2/25/2016 (nms). (Entered: 02/25/2016)

2016-02-25

1

View

SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. The above-captioned actions are hereby consolidated for all discovery and validity trial, but not for infringement trials, into C.A. No. 15-1000-RGA. From this point forward, all filings pertaining to any of the above-captioned actions shall be filed on the docket in C.A. No. 15-1000-RGA. Joinder of Parties due by 12/31/2016. Amended Pleadings due by 12/31/2016. Fact Discovery completed by 6/8/2017. Joint Claim Construction Opening Brief due by 1/25/2017. A Markman Hearing is set for 2/14/2017, at 8:30 AM in Courtroom 6A before Judge Richard G. Andrews. A Pretrial Conference is set for 3/16/2018, at 8:30 AM in Courtroom 6A before Judge Richard G. Andrews. A 3 day Bench Trial on validity issues is set for 3/26/2018, at 8:30 AM in Courtroom 6A before Judge Richard G. Andrews. One day Bench Trials are set for 4/2/2018, at 8:30 AM in Courtroom 6A; 4/4/2018, at 8:30 AM in Courtroom 6A; 4/6/2018, at 8:30 AM in Courtroom 6A; 4/9/2018, at 8:30 AM in Courtroom 6B; 4/11/2018, at 8:30 AM in Courtroom 6A; 4/13/2018, at 8:30 AM in Courtroom 6A; 4/16/2018, at 8:30 AM in Courtroom 6A; 4/18/2018, at 8:30 AM in Courtroom 6A; 4/20/2018, at 8:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 2/25/2016. Associated Cases: 1:15-cv-00999-RGA et al.(nms) (Entered: 02/25/2016)

2016-02-25

1

View

ORAL ORDER: On or before March 10, 2016, each party or each party group shall email to Chief Magistrate Judge Thynge, with a copy to her Judicial Administrator, Cathleen Kennedy, the information requested in the attached Order. Ordered by Judge Thynge on 2/25/16. (Attachments: # 1 Order Requesting Information re: ADR) Associated Cases: 1:15-cv-00999-RGA et al.(cak) (Entered: 02/25/2016)

2016-02-25

1

View

Case Referred to Mediation - Magistrate Judge only

2016-02-25

1

No Actions

CORRECTING ENTRY: The Notice of Service filed at D.I. 24 has been removed from the docket per the Order filed at D.I. 21 . (nms)

2017-06-16

1

No Actions

- CORRECTING ENTRY

2017-06-16

1

No Actions

CORRECTING ENTRY: The Notice of Service filed at D.I. 23 has been removed from the docket per the Order filed at D.I. 21 . (nms)

2017-06-16

1

No Actions

- CORRECTING ENTRY

2017-06-16

1

No Actions

ORDER Administratively Closing Case (see Order for further details). Signed by Judge Richard G. Andrews on 1/11/2018. (nms) (Entered: 01/11/2018)

2018-01-11

1

View

CASE CLOSED per entry of Consent Judgment (D.I. 486) in Lead Civil Action 15-1000-RGA. (nms)

2019-01-02

1

No Actions

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,251,910; 6,525,060; 7,250,419; 7,265,124; 8,425,934. (Attachments: # 1 Consent Judgment)(nms) (Entered: 01/03/2019)

2019-01-03

1

View

Overview

Parties

Counter Claimant

Prinston Pharmaceutical Inc. Follow

Represented By

Defendant

AstraZeneca AB Follow

Represented By

AstraZeneca LP Follow

Represented By

Plaintiff

AstraZeneca UK Limited Follow

Represented By

Movant

AstraZeneca Pharmaceuticals LP Follow

Represented By

Court & Judges

Patents Involved

Docket Entries

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (sec) (Entered: 11/16/2015)

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 10/03/2015. Date of Expiration of Patent: SEE ANDA.Thirty Month Stay Deadline: 1/20/2019. (sec) (Entered: 11/16/2015)

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,251,910; 6,525,060; 7,250,419; 7,265,124; 8,425,934. (sec) (Entered: 11/16/2015)

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for AstraZeneca LP filed by AstraZeneca LP. (sec) (Entered: 11/16/2015)

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for AstraZeneca AB filed by AstraZeneca AB. (sec) (Entered: 11/16/2015)

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for AstraZeneca UK Limited filed by AstraZeneca UK Limited. (sec) (Entered: 11/16/2015)

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for AstraZeneca Pharmaceuticals LP filed by AstraZeneca Pharmaceuticals LP. (sec) (Entered: 11/16/2015)

Summons Issued

Case Assigned/Reassigned

SUMMONS Returned Executed by AstraZeneca LP, AstraZeneca UK Limited, AstraZeneca Pharmaceuticals LP, AstraZeneca AB. Prinston Pharmaceutical Inc. served on 11/17/2015, answer due 12/8/2015. (Smyth, Benjamin) (Entered: 11/25/2015)

STIPULATION TO EXTEND TIME Answer to Complaint to through and including January 8, 2016 - filed by Prinston Pharmaceutical Inc.. (Farnan, Kelly) (Entered: 12/04/2015)

~Util - Set/Reset Answer Deadline AND SO ORDERED

SO ORDERED

Add Attorneys - PHV only

ANSWER to 1 Complaint, with Jury Demand, COUNTERCLAIM against AstraZeneca AB, AstraZeneca LP, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited by Prinston Pharmaceutical Inc..(Farnan, Kelly) (Entered: 01/08/2016)

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Zhejiang Huahai Pharmaceutical Co., Ltd. for Prinston Pharmaceutical Inc. filed by Prinston Pharmaceutical Inc.. (Farnan, Kelly) (Entered: 01/08/2016)

MOTION for Pro Hac Vice Appearance of Attorney Steven E. Feldman, Daniel R. Cherry and Sherry L. Rollo of Hahn Loeser & Parks LLP - filed by Prinston Pharmaceutical Inc.. (Farnan, Kelly) (Entered: 01/13/2016)

SO ORDERED

Order Setting Rule 16(b) Conference: A Scheduling Conference is set for 2/10/2016, at 2:30 PM in Courtroom 6A before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 1/14/2016. (nms) (Entered: 01/19/2016)

NOTICE of Appearance by Christine Dealy Haynes on behalf of Prinston Pharmaceutical Inc. (Haynes, Christine) (Entered: 01/26/2016)

Add Attorneys - PHV only

ANSWER to 12 Answer to Complaint, Counterclaim by AstraZeneca AB, AstraZeneca LP, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited.(Silver, Daniel) (Entered: 02/01/2016)

Proposed Scheduling Order, by AstraZeneca AB, AstraZeneca LP, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited. (Silver, Daniel) Modified on 2/9/2016 (nms). (Entered: 02/08/2016)

Scheduling Conference

PROPOSED Scheduling Order, by AstraZeneca AB, AstraZeneca LP, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited. (Silver, Daniel) Modified on 2/25/2016 (nms). (Entered: 02/25/2016)

Case Referred to Mediation - Magistrate Judge only

CORRECTING ENTRY: The Notice of Service filed at D.I. 24 has been removed from the docket per the Order filed at D.I. 21 . (nms)

- CORRECTING ENTRY

CORRECTING ENTRY: The Notice of Service filed at D.I. 23 has been removed from the docket per the Order filed at D.I. 21 . (nms)

- CORRECTING ENTRY

ORDER Administratively Closing Case (see Order for further details). Signed by Judge Richard G. Andrews on 1/11/2018. (nms) (Entered: 01/11/2018)

CASE CLOSED per entry of Consent Judgment (D.I. 486) in Lead Civil Action 15-1000-RGA. (nms)

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,251,910; 6,525,060; 7,250,419; 7,265,124; 8,425,934. (Attachments: # 1 Consent Judgment)(nms) (Entered: 01/03/2019)

Track Case Updates

Prinston Pharmaceutical Inc.

AstraZeneca AB

AstraZeneca LP

AstraZeneca UK Limited

AstraZeneca Pharmaceuticals LP